Whether you’re trying to better understand biology pathways, monitor disease progression, or evaluate potential drug candidates earlier in the development process, Revvity’s portfolio of preclinical in vivo imaging solutions – from standalone optical and microCT imaging, to integrated systems – are designed to meet your needs.

With more than a decade of experience in this field, Revvity provides a portfolio of high-content screening products – imaging instruments, software, automation, fluorescent probes and microplates – to help you answer complex biological questions. Both Opera Phenix® Plus and Operetta™ CLS high-content imaging systems incorporate confocal spinning disk technology and produce images of exceptional quality. From basic research to assay development and screening, Revvity’s high-content analysis products are designed to help you take your research further, in less time than ever before.

Revvity’s multimode, microplate readers cater for all major detections such as, Absorbance, Alpha, Luminescence, Fluorescence Intensity, Fluorescence Polarization, and Time-Resolved Fluorescence, all in one instrument. In addition to the detection technologies, Revvity’s EnSight™ multimode plate reader also offers fast well-imaging so you can perform target-based and phenotypic screening to gain valuable insights from different perspectives.

Browse Revvity’s reagents for in vivo imaging solutions, as well as high-content screening analysis. In addition, Revvity offers a range of consumables and chemicals for life science research applications.

Through collaborations with academia and the biotech and pharma industries, Revvity creates solutions that drive labs forward, with products ranging from brightfield and fluorescent cell viability counters to high-throughput automated image cytometry workstations for cell quantification, analysis, and cell-based assays.